Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
Clinical trial NCT02133183 · TERMINATED
Trial details
- NCT number
- NCT02133183
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-02
- Primary completion
- 2020-01-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.